This author has yet to write their bio.Meanwhile lets just say that we are proud PR Newswire contributed a whooping 1093 entries.
Brand Institute, the global leader in pharmaceutical and healthcare-related brand name and identity development, is pleased to share that Denmark-based Bavarian Nordic’s smallpox and monkeypox vaccine, named JYNNEOS®, was selected by TIME Magazine as one of the best inventions of 2022.
Kintara Therapeutics Inc., a biopharmaceutical company focused on the development of new solid tumor cancer therapies, announced that the United States Food and Drug Administration (FDA) has granted Fast Track Designation (FTD) to Kintara’s REM-001 Therapy for the treatment of patients with cutaneous metastatic breast cancer (CMBC).
After eight years in leadership roles at Vaniam Group, Herzog’s appointment demonstrates the agency’s continued focus on client service, operational excellence, and healthy growth.
Young adults are conducting a new kind of breast cancer check thanks to Young Survival Coalition, Lizzo’s shapewear brand YITTY, and OHG’s Purpose Group, made up of Patients & Purpose and Science & Purpose.
As the rapid evolution of the health and wellness sector continues to necessitate innovative thinking and activation across the industry, Havas Health & You appointed seasoned strategic leader Paul Pfleiderer as President of Havas Life New York. Pfleiderer will work closely with Havas Life Group President Denise Henry to drive the agency’s growth and strengthen its market leadership presence through exceptional client work and culture.
The company is touting the platform as the first fully digital clinical trial solution for oncology, hematology, and urology.
Recent studies have shown that patients with weakened immune systems — which enables the virus that causes COVID-19 to remain longer in the body, copy itself, and continually change — may enable the development of new, slightly different versions of the virus (variants).
The Novartis Foundation in collaboration with Microsoft AI for Health and NYU School of Global Public Health are utilizing artificial intelligence combined with anonymized population data from numerous sources to get a more fundamental assessment of heart health inequities in New York City.
In the decision, a judge ruled for Illumina and rejected the FTC’s position that the deal would adversely affect competition in a putative market for multi-cancer early detection (MCED) tests.
Britain’s medicines regulator on Friday approved Novavax’s COVID-19 vaccine for children aged between 12 and 17 years.